Product Information

TOBRAMYCIN 80 MG/2 ML VIAL is a generic product labeled by Mylan Institutional LLC, priced at $0.9707 per ML under NDC 67457047322. Its NADAC has been published 188 times since Aug 18, 2021.

FDA first approved this application on Mar 11, 2008. Its Orange Book therapeutic-equivalence code is AP.

The Low Outlier badge above means this manufacturer's average price in the Tobramycin market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TOBRAMYCIN 80 MG/2 ML VIAL

Tobramycin
$0.9707per ML
Low Outlier

Strength

40 mg/mL

NDC

67457047322

Classification

Generic

Dosage Form

INJECTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

11/18/2026

Active Ingredients

TOBRAMYCIN SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA065407

FDA Approved

3/11/2008

TE Code

AP

On Market Since

8/19/2014

Pharmacological Classes

Price Statistics

The NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has been published 188 times since Aug 18, 2021, and over the history we have for it it has risen 14.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9707 per ML
All-time high$0.9707 (Nov 18, 2026)
All-time low$0.5997 (Mar 18, 2026)
52-week high$0.9707
52-week low$0.5997
Median price$0.8315
Average price$0.8038
Largest weekly change-16.2% (Nov 20, 2024)
Weeks tracked188
Tracking sinceAug 18, 2021

Price History

1W

+4.6%

1M

+4.6%

3M

+31.3%

6M

+51.4%

1Y

+15.9%

3Y

+14.3%

5Y

+14.3%

All

+14.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOBRAMYCIN 80 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 80 MG/2 ML VIAL, manufactured by Mylan Institutional LLC, is $0.9707 per ML (NDC 67457047322), effective Nov 18, 2026.

How has the price of TOBRAMYCIN 80 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has risen 14.3%. It has been tracked across 188 weekly CMS publications since Aug 18, 2021.

What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 80 MG/2 ML VIAL?

Since Aug 18, 2021, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has ranged from a low of $0.5997 (Mar 18, 2026) to a high of $0.9707 (Nov 18, 2026), with a median of $0.8315 per ML.

Are there cheaper alternatives to TOBRAMYCIN 80 MG/2 ML VIAL?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TOBRAMYCIN 80 MG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.

Who manufactures TOBRAMYCIN 80 MG/2 ML VIAL?

TOBRAMYCIN 80 MG/2 ML VIAL (NDC 67457047322) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.